Coegin Pharma

Coegin Pharma hereby announces that the company will change its language for communication to English only. This means that financial reports and press releases will henceforth be published exclusively in English.

Coegin Pharma operates in a global market and has an extensive network of international stakeholders. By transitioning to English as the language of communication, the company aims to create more consistent and effective communication, simplifying the dissemination of information to its stakeholders.

Historical press releases and financial reports in Swedish will remain available on the company's website. 

For further information, please contact:
Jens Eriksson, CEO
Email: info@coeginpharma.com

About Coegin Pharma
Coegin Pharma is a Swedish biotech company developing cutting-edge innovations for hair and skin. The company aims to commercialise a series of hair growth products starting in late 2025, followed by a pigmentation product in 2026.

The company's vision is: "To lead the future of cutting-edge solutions for hair and skin longevity".

Coegin Pharma's share is listed on NGM Nordic SME and dual-listed on Börse Stuttgart. The company is headquartered in Lund, Sweden.

More information - including subscription to company updates and links to social media - is available at coeginpharma.com